Stock Price
0.41
Daily Change
-0.01 -2.38%
Monthly
17.14%
Yearly
310.00%
Q1 Forecast
0.37

Starpharma Holdings reported AUD-1.03M in EBIT for its fiscal semester ending in December of 2023.





Ebit Change Date
Medical Developments International AUD -12.12M 3.97M Jun/2023
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024